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Abstract The lack of a simple, objective and reproducible
system to describe glioblastoma multiforme (GBM) repre-
sents a major limitation in comparative effectiveness research.
The objectives of this study were therefore to develop such a
grading system and to validate it on patients who underwent
surgical resection. A systematic review of the literature was
performed to identify features on pre-operative magnetic res-
onance imaging (MRI) that predict the surgical outcome of
patients with GBM. In all, the five most important features
of GBM on pre-operat ive MRI were as fol lows:
periventricular or deep location, corpus callosum or bilateral
location, eloquent location, size and associated oedema. These
were then used to develop a grading system. To validate this
grading system, a retrospective cohort study of all adult pa-
tients with supratentorial GBMwho underwent surgical resec-
tion between the 1 January 2014 and the 31 June 2015 was
performed. There was a substantial agreement between the
two neurosurgeons grading GBM (Cohen’s κwas 0.625; stan-
dard error 0.066). High-complexity lesions were significantly
less likely to result in complete resection of contrast-
enhancing tumour than low-complexity lesions (50.0 versus
3.4%; p = 0.0007). The proposed grading system may allow
for the standardised communication of anatomical features of
GBM identified on pre-operative MRI.
Keywords Glioblastomamultiforme .Magnetic resonance
imaging . Surgical outcome . Complications . Resection
Introduction
The surgical management of patients with glioblastoma
multiforme (GBM) remains contentious with a paucity of
high-quali ty evidence to guide decision making.
Nonetheless, the nihilism associated with GBM is gradually
diminishing. A randomised study concluded that, even in the
elderly, surgical resection was superior to biopsy alone [43].
More recently, cohort studies have found that complete resec-
tion of enhancing tumour results in prolonged survival [27,
29, 34, 39]. However, in the largest prospective study on pa-
tients with GBM, complete resection was only achieved in
approximately a third of patients, suggesting difficulty in de-
fining marginal, enhancing tumour intra-operatively using
conventional microsurgical techniques [38].
A multitude of surgical innovations have been introduced
to maximise the resection of GBM including fluorescence-
guided surgery and various other intraoperative imaging tech-
niques [3, 20, 26]. Over the next decade, emerging technolo-
gies such as confocal laser endomicroscopy, rapid evaporative
ionisation mass spectrometry and Raman spectroscopy are
expected to further expand the surgical armamentarium [2,
19, 24].
Selecting from the aforementioned array of surgical inno-
vations is difficult. The operative techniques used for the
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resection of GBM have historically been based on a surgeon’s
training and experience and the local availability of resources.
The Balliol Collaboration has proposed the Idea,
Development, Exploration, Assessment and Long-term fol-
low up (IDEAL) model for surgical innovation; the central
tenet being that innovation and evaluation should proceed
together [13, 17, 31]. Evaluation of surgical innovations that
maximise the resection of GBM is especially challenging be-
cause of the heterogeneity in tumour anatomy and the com-
plexity of surgical resection.
In other cerebral pathologies such as arteriovenous malfor-
mation (AVM), several anatomical features on pre-operative
imaging have been found to predict surgical outcome includ-
ing size, relationship with eloquent structures and pattern of
venous drainage [37]. The lack of a similarly simple, objective
and reproducible system to describe GBM represents a major
limitation in comparative effectiveness research. The aims of
this study were therefore to (1) identify features on standard
pre-operative magnetic resonance imaging (MRI) that predict
the surgical outcome of patients with GBM and use these to
develop a grading system and (2) validate this grading system
on patients who have underwent surgical resection.
Materials and methods
Development
A systematic review of the literature was performed to identify
features on pre-operative MRI that predict the surgical out-
come of patients with GBM. The Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) state-
ment was used in the preparation of this section of the manu-
script [32].
Inclusion and exclusion criteria
Articles that (1) featured adult patients (greater than 18 years
of age) with supratentorial GBM undergoing surgical resec-
tion and (2) reported on the use of pre-operative MRI to pre-
dict residual disease or survival were included. Articles that
used advanced imaging techniques such as segmentation and
volumetric analysis, which are not widely available, were
excluded.
Information sources, search strategy and study selection
The PubMed database was searched between 1 January 1995
and 31 June 2015 using the search terms (glioblastoma OR
Bmalignant glioma^OR Bhigh grade glioma^OR Bhigh-grade
glioma^) AND (pre-operative OR preoperative OR preop OR
pre-op) AND (prediction OR predictive OR scoring OR score)
AND (outcome OR resection OR resectability OR
Bprogression free survival^ OR PFS OR Boverall survival^
OR OS).
Titles and abstracts were screened to identify articles that
met appeared to meet the inclusion criteria (HJM and AHH;
both clinical research fellows). Full papers were then retrieved
for detailed review. Discrepancies were resolved by consensus
and discussion with the senior author.
Data collection process and data items
The following data were extracted from selected articles (HJM
and AHH): (1) study design, (2) patient characteristics, (3)
pre-operative MRI features, (4) surgical outcomes and (5)
findings.When both univariate andmultivariate analyses were
presented, we preferentially included the more significant
findings. Corresponding authors were contacted to provide
supplemental data when required.
Development of grading system
The pre-operative MRI features most frequently used to pre-
dict surgical outcomes were used to develop a grading system.
Features were selected such that the proposed grading system
made clinical sense and could be easily incorporated into prac-
tice using a standard contrast-enhanced T1-weighted MRI.
Validation
A retrospective cohort study was performed to validate the
grading system. The Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) statement
was used in the preparation of this section of the manuscript
[42].
Setting and participants
The study was conducted at Charing Cross Hospital, which
acts as regional referral centre for brain tumours in NorthWest
London. The centre comprises three specialist neurosurgeons,
who spend at least half of their clinical programmed activity in
neurooncological surgery.
All referrals were recorded on a prospectively maintained
database. The database was searched between the 1 January
2014 and the 31 June 2015 to identify all adult patients with
supratentorial GBM who underwent craniotomy and resec-
tion. Patients who underwent a burr hole and stereotactic bi-
opsy only were excluded.
Variables and data sources
All patients with GBM received therapy according to the
National Institute of Clinical Excellence (NICE) guidance,
including the following: high-dose dexamethasone,
622 Neurosurg Rev (2017) 40:621–631
discussion of their case in a dedicated neurooncology multi-
disciplinary meeting, pre-operative MRI with contrast, image-
guided craniotomy and microsurgical resection and post-
operative MRI with contrast within 72 h of surgery.
Intraoperative ultrasound was available but was used accord-
ing to surgeon preference.
The pre-operative contrast-enhanced T1-weighted MRI
scans were graded by two neurosurgeons blinded to the out-
come. The post-operative contrast-enhanced T1-weighted
MRI scan was evaluated by a consultant neuroradiologist
blinded to the grade to determine the extent of resection (com-
plete resection of all contrast-enhancing tumours or not). All
images were reviewed on standard display monitors.
A retrospective case note review was also performed to
identify any immediate surgical complications, which were
recorded according the Clavian-Dindo classification [12,
15]. The strength of this classification system is that it largely
relies on the therapy used to treat the complication, which are
easily identified in retrospective analyses.
Study size and statistical methods
It was estimated using pilot data that the previous criteria would
identify approximately 100 patients. Based on similar studies
validating grading systems in other cerebral pathologies, we
considered 100 patients sufficient for meaningful analysis [37].
Data were analysed using with SPSS v 20.0 (IBM, Illinois,
USA). The mean and standard deviation were calculated for
parametric variables, and the median and interquartile ranges
were calculated for non-parametric variables. Cohen’s κ was
calculated to determine the agreement between the two neu-
rosurgeons grades. The chi-square test was then used to (1)
compare the grade against extent of resection and (2) compare
the grade against the presence of major complications





In all, 99 article titles and abstracts were screened, 25 full
articles were considered relevant and further assessed for their
eligibility, and 20 articles were ultimately included (Fig. 1).
Study characteristics
The included studies comprised one prospective cohort study,
18 retrospective cohort studies and one case-control study.
The patient characteristics, pre-operative MRI features, surgi-
cal outcomes and findings are summarised in Table 1.
Grading system
Five features on pre-operative MRI were identified that were
found to be predictive of surgical outcome in at least two studies
(Table 2): periventricular or deep location, corpus callosum or
bilateral location, eloquent location, size and associated oede-
ma. These features were used to develop a grading system for
adult patients with supratentorial GBM (Table 3).
The grading system was designed to be simple, objective
and reproducible. Each feature is measured on a standard pre-
opera t ive cont ras t -enhanced T1-weighted MRI:
periventricular or deep location if the contrast-enhancing tu-
mour is located within 10 mm of the ventricles; corpus
Records identified in PubMed
(n = 99)









No use of routine pre-operative MRI (n = 2)
No relevant surgical outcome (n = 3)
Studies included in analysis
(n = 20)
Fig. 1 Selection of articles that
identify features on pre-operative
MRI that predict the surgical out-
come of patients with GBM
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Table 1 Summary of study characteristics
First author
(year)
Study design Patients characteristics Pre-operative MRI features Surgical
outcomes
Findings
[1] Case-control study n = 100 with GBM; 50
pts with long OS, 50






OS OS reduced if both hemispheres
involved (p = 0.074, univariate)
OS reduced with periventricular
location (p = 0.038, univariate)
[4] Retrospective cohort study n = 54 with GBM Volume
Periventricular location
EOR EOR reduced with increased volume
(p < 0.05, univariate)
EOR reduced with periventricular
location (p < 0.05, univariate)
[6] Retrospective cohort study n = 52 with GBM; 26
pts with
periventricular




OS OS reduced with periventricular
location (p = 0.02, univariate)
[7] Retrospective cohort study
to construct and validate
scoring system




OS OS reduced with periventricular
location (p = 0.04, multivariate)





OS OS reduced with increased diameter
(p = 0.002, multivariate)
[9] Multicentre retrospective
cohort study to validate
scoring system
n = 334 with GBM Periventricular location OS OS reduced with periventricular
location (p = 0.04, multivariate)





OS OS increased with increased
diameter > 2 cm (p = 0.01,
multivariate)







EOR, PFS and OS reduced with corpus
callosum involvement (p < 0.001,
p = 0.006 and p = 0.011
respectively; multivariate)
[16] Retrospective cohort study n = 46 with GBM Brain lobe
Diameter
OS OS reduced with temporal location
(p = 0.0130, multivariate)
OS reduced with increased diameter
(p = 0.0395, multivariate)




OS OS reduced with necrosis (p < 0.001,
multivariate)
OS reduced with enhancement
(p = 0.003, multivariate)
OS reduced with oedema (p < 0.004,
multivariate)
[22] Retrospective series n = 516 with GBM Laterality OS OS reduced if both hemispheres
involved (p < 0.01, multivariate)









NER crossing the midline (OS
p = 0.0125, PFS p = 0.0661,
multivariate).




OS No significant associations found.






OS OS reduced with necrosis (p = 0.01,
multivariate) OS reduced with
contrast enhancement (p = 0.02,
multivariate) OS reduced with
eloquent location (p = 0.02,
univariate) OS reduced with oedema
(p = 0.04, univariate)
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callosum or bilateral location if contrast-enhancing tumour
extends into these regions; eloquent if contrast-enhancing tu-
mour extends into motor or sensory cortex, language cortex,
insula or basal ganglia; large if the diameter of the contrast-
enhancing tumour exceeds 40 mm; and associated oedema if
hypo-intensity extends more than 10 mm from contrast-
enhancing tumour. All features are weighted equally, with
one point assigned if a feature was present and no points if
absent. The sum of these features is used to describe lesions as
low (0–1 points), moderate (2–3 points) and high complexity
(4–5 points). An example of a high-complexity tumour is
illustrated in Fig. 2.
The grading system uses a standard pre-operative contrast-
enhanced T1-weighted MRI as such imaging is readily avail-
able, allowing the grading system to be used in resource-
limited settings and in retrospective studies. The radiological
definitions of periventricular or deep location, large diameter
and associated oedema were drawn from the literature and,
where there was discrepancy, using the expert opinion of the




Study design Patients characteristics Pre-operative MRI features Surgical
outcomes
Findings










PFS was dependent upon brain lobe
(p = 0.001, multivariate)
OS reduced with deep or eloquent
location (p = 0.009, multivariate)
[30] Retrospective cohort study n = 205 with GBM Deep or eloquent location OS OS reduced with deep or eloquent
location (p < 0.0001, multivariate)
[33] Multicentre retrospective
cohort study to construct
and validate scoring
system
n = 143 with recurrent
GBM; 34 pts to
devise scoring system






OS OS reduced with greater volume
(p < 0.001, univariate)
OS reduced with eloquent location
(p < 0.001, univariate)
[35] Multicentre retrospective
cohort study
n = 110 with GBM Diameter
Associated oedema
OS OS reduced with associated oedema
(p = 0.006, multivariate)
[39] Retrospective cohort study
(using prospectively
collected trial data)
n = 243 with GBM; 121
pts received 5-ALA,









EOR reduced with eloquent location
(p = 0.0231, univariate)





OS OS reduced with periventricular
location (p = 0.008, multivariate)
pts patients, GBM glioblastoma multiforme,HGG high-grade glioma, EOR extent of resection, PFS progression-free survival, OS overall survival, KPS
Karnofsky Performance Status score, CER contrast-enhancing region, NER non-enhancing region
Table 2 Summary of pre-
operative features that predict
surgical outcome
Pre-operative MRI feature Number of studies
that analysed
Number of studies that found
feature predictive of outcome
Periventricular or deep locationa 12 8
Eloquent location 8 5
Sizeb 13 5
Associated oedema 6 3
Corpus callosum involvement or bilateral locationc 6 2
Only features with >2 studies supporting their use were included
a Periventricular and deep location were combined
bDiameter and volume were combined
c Corpus callosum and bilateral location were combined
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equally, and the sum of these features is used to describe
lesions as low, moderate and high complexities, to ensure that
the grading system is as simple as possible and to increase the
statistical power for series comparisons.
Validation
Participants and descriptive data
In all, 106 patients were identified with supratentorial GBM
who underwent craniotomy and resection. Of these, 18
patients were excluded because their imaging (n = 9) or clin-
ical notes (n = 9) could not be found, and 88 patients were
included. The patient demographics are summarised in
Table 4.
Outcome data and main results
Pre-operative MRI features are summarised in Table 5. The
majority of tumours had a periventricular location (77.3%; 68/
88), were greater than 40 mm in diameter (70.5%; 62/88) and
had significant associated oedema (69.3%; 61/88). Corpus
callosum involvement, or bilateral location, was seen in
33.0% of tumours (29/88), while eloquent location involve-
ment was seen in 43.2% (38/88) of tumours.
Post-operative MRI demonstrated complete resection of
contrast-enhancing tumour in 15 patients (17.0%). Three pa-
tients (3.4%) had major complications: two had intracerebral
haemorrhage, and one had massive pulmonary embolism.
Table 3 The proposed grading
system for adults with
supratentorial GBM
Pre-operative MRI feature Score
Periventricular or deep location
≥10 mm from ventricle 0
<10 mm from ventricle 1
Corpus callosum or bilateral location
No corpus callosum involvement 0
Corpus callosum involvement or bilateral location 1
Eloquent location
Not eloquent location 0
Eloquent location (motor or sensory cortex, language
cortex, insula or basal ganglia)
1




<10 mm from contrast-enhancing tumour 0





All features are assessed using the pre-operative contrast-enhanced T1-weighted MRI
Fig. 2 Example of a high-complexity lesion (5 points) on pre-operative
contrast-enhanced T1-weighted MRI




- (interquartile range) 59 years (46–70)
GBM
- primary: recurrent 7:1
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There was a substantial agreement between the two neuro-
surgeons grading GBM (Cohen’s κ was 0.625; standard error
0.066). The grades and surgical outcomes are summarised in
Table 6 and Fig. 3. There was a significant association be-
tween grades and extent of resection (p = 0.0007) but not
complications (p = 0.4148).
Discussion
Principal findings
Currently, the literature on GBMmanagement contains limited
data on relevant surgical anatomy. When such data are avail-
able, it is often described in a variable manner, making com-
parative effectiveness research difficult. This study reports the
development and validation of a simple, objective and repro-
ducible grading system for GBM. The proposed grading system
allows for the standardised reporting of the five most important
features of GBM on pre-operative MRI: periventricular or deep
location, corpus callosum or bilateral location, eloquent loca-
tion, size and associated oedema. Moreover, this grading sys-
tem was found to be predictive of surgical outcome. High-
complexity lesions were significantly less likely to result in
complete resection of contrast-enhancing tumour than low-
complexity lesions (50.0 versus 3.4%; p = 0.0007). High-
complexity lesions were also more likely to result in major
complications, though this did not achieve statistical signifi-
cance (6.9 versus 0%; p = 0.4148).
Comparison with other studies
Each element of the proposed grading system has been previ-
ously identified in the literature as affecting surgical outcome.
The most consistently reported of these elements is GBM near
the ventricles, or deep location, which eight articles found to
be associated with reduced extent of resection and overall
survival. The resection of deep-seated GBM necessitates pial
and subpial transection. Multiple studies have demonstrated
that lesions of the deep white matter tracts elicit more severe
and permanent neurological deficits than cortical injuries of
comparable volume, making the complete resection of
contrast-enhancing tumour challenging [18]. Benveniste
et al. found that, for tumours under 30 ml in volume, only
77% of those lying adjacent to the ventricles were completely
resected, compared to 91% of those lying elsewhere.
Emerging technologies such as high-definition fibre
tractography and endoscopic port surgery may improve the
Table 5 Features as assessed
using the pre-operative contrast-
enhanced T1-weighted MRI
Pre-operative MRI feature Number
Periventricular or deep location
≥10 mm from ventricle 20 (22.7%)
<10 mm from ventricle 68 (77.3%)
Corpus callosum or bilateral location
No corpus callosum involvement 59 (67.0%)
Corpus callosum involvement or bilateral location 29 (33.0%)
Eloquent location
Not eloquent location 50 (56.8%)
Eloquent location (motor or sensory cortex, language cortex, insula or basal ganglia) 38 (43.2%)




<10 mm from contrast-enhancing tumour 27 (30.7%)
≥10 mm from contrast-enhancing tumour 61 (69.3%)
Total 88
Table 6 Grade and surgical
outcome Grade Number Complete resection of
contrast-enhancing tumour
Major complications
Low complexity(0–1 points) 14 7 (50.0%) 0 (0%)
Moderate complexity(2–3 points) 45 7 (15.6%) 1 (2.2%)
High complexity(4–5 points) 29 1 (3.4%) 2 (6.9%)
Total 88 15 (17.0%) 3 (3.4%)
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visualisation and resection of tumours lying near the ventricles
[5, 18, 40].
The presence of cerebral oedema associated with GBM is a
common feature on pre-operative MRI and is known to affect
overall survival. All the patients in our cohort were given high-
dose dexamethasone pre-operatively, and in more than two
thirds, major oedema persisted on imaging. Major oedema
can result in considerable difficulty during surgical resection,
obscuring identification of anatomical landmarks and making
brain tissue less amenable to manipulation. To this end, evi-
dence suggests that minimal oedema is associated with in-
creased overall survival (albeit only with univariate analysis),
while major oedema, extending more than 10 mm from the
tumour margin, is associated with reduced survival [21, 27, 35].
It has long been recognised that individual tumour cells
frequently spread into the contralateral hemisphere in patients
with GBM [14]. However, only a third of patients in our
cohort were found to have contrast-enhancing tumour infil-
trate the corpus callosum on pre-operative MRI. The surgical
resection of lesions within the corpus callosum, particularly
the posterior region, can result in major complications such as
disconnection syndrome. Infiltration of the corpus callosum is
therefore associated with significantly reduced extent of resec-
tion, reduced progression-free survival and reduced overall
survival [11]. Similarly, tumours extending into both hemi-
spheres are associated with worse overall survival [1, 22].
Larger GBM, assessed by both linear and volumetric pa-
rameters, is associated with reduced extent of resection and
worse overall survival [4, 8, 10, 16, 33]. A number of metrics
have been used to dichotomise tumours according to size,
including a tumour volume greater than 30 ml or a maximal
diameter greater than 2 or 40mm [4, 7, 10]. As volumetric and
linear metrics have been shown to be comparable and linear
metrics are more straightforward tomeasure on standardMRI,
we used a maximal diameter greater than 40 mm in the pro-
posed grading system.
Several studies have identified GBM located within elo-
quent regions as a negative predictor of extent of resection
and overall survival [16, 27, 28, 30, 33, 39]. The regions
considered eloquent vary in the literature, but those most com-
monly included were used in the proposed grading system
(motor or sensory cortex, language cortex, insula or basal
ganglia). Historically, complete resection of lesions residing
within these regions was believed to invariably result in per-
manent neurological deficits. Recent evidence, however,
points to considerable plasticity within these regions, and
techniques such as awake craniotomy may yet allow for com-
plete resection of contrast-enhancing tumours in selected
cases [40].
Taken together, the five aforementioned pre-operative MRI
features have a major impact on surgical outcome. Studies
comparing different operative techniques must therefore care-
fully account for these confounders. Although the overall rate
of complete resection in our preliminary validation study was
modest compared to the literature (17.0%; 15/88), the rate of
complete resection of contrast-enhancing tumour varied wide-
ly from 3.4% in high-complexity lesions (4–5 features) to
50.0% in low-complexity lesions (0–1 features). In the largest
prospective study on patients with GBM, only 36% of patients
were found to have their complete resection of contrast-
enhancing tumour using conventional microsurgical tech-
niques [38]. Other studies, which report a rate of complete
resection of contrast-enhancing tumour in up to 90% of cases,
are usually retrospective, often exclude patients in whom
complete resection is deemed impossible such as those involv-
ing the corpus callosum or eloquent brain, and may combine
near total and gross total resection in their analyses [36].
To the best of our knowledge, the proposed grading system
is the first to use features on pre-operative MRI to predict the
surgical outcome of adult patients undergoing craniotomy for
GBM. However, several other systems have been described
that use a combination of demographic, clinical and radiolog-
ical features to predict overall survival. Chaichana et al. de-
veloped a system that included the patient’s Karnofsky
Performance Status, age, the presence of a motor deficit, the
presence of a language deficit and periventricular tumour lo-
cation. This system was initially validated on 393 prospective
cases at one centre and then later on 334 patients across three
centres [10]. Park et al. developed a similar system using the
Karnofsky Performance Status, tumour volume and tumour
location within eloquent or critical regions, which was vali-
dated on a retrospective cohort of 34 consecutive patients at
one centre [33]. Although these systems are useful, the pro-
posed grading system differs in focusing on anatomical fea-
tures of GBM that influence the operative complexity and
Fig. 3 Grade and surgical outcome
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therefore the extent of resection and likelihood of major
complications.
Limitations
There were several limitations to the validation of the pro-
posed grading system. First, the retrospective nature of the
study introduces the possibility of, for example, selection bias.
The accurate and precise recording of patient complications,
in particular, is difficult in such study designs. Second, the
single-centre design makes it difficult to generalise the find-
ings to different centres with different patient populations,
case selection and operative techniques. Third, the study was
powered to validate the grading system with respect to extent
of resection, but not major complications. Finally, the study
did not measure important other surgical outcomes such as
progression-free survival and overall survival. These limita-
tions might be addressed through prospective, multicentre and
larger studies.
Conclusions
The proposed grading system may allow for the standardised
communication of anatomical features of GBM identified on
pre-operative MRI.While the grading systemmay not capture
all the elements that contribute to the complexity of individual
cases, we believe that it captures the most relevant character-
istics in a reproducible manner. We hope that use of this grad-
ing system in clinical practice and in the literature will enable
more standardisation of clinical care and more meaningful
comparisons of clinical studies.
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